Federal AI Intelligence
Menu
Snapshot · OMB 2025 inventory · processed Oct 11, 2026
Governance and accountability

Governance evidence

What agencies reported about the OMB M-25-21 minimum practices for high-impact AI. This is a disclosure analysis, not an audit, a compliance finding or an official assessment. An unanswered question is missing evidence, not evidence that a safeguard is absent.

Agency
Stage1
High-impact
Topic1
AI type1
Sourcing
Vendor
Function
Start year

Only records with a parseable start date match a year filter.

AI type: Generative AIStage: DeployedTopic: Health and Medical

Practice-by-practice evidence

Denominator: 2 records · use cases designated high-impact
Reported in placeReported in progressNot applicableNo answer reported
PracticeIn scopeIn placeIn progressNot in placeN/APrecluded or waivedOtherNo answerAnsweredIn place of applicable
Pre-deployment testing2100000150%50% of 2
AI impact assessment2010000150%0% of 2
Independent review2010000150%0% of 2
Ongoing monitoring2100000150%50% of 2
Operator training2100000150%50% of 2
Fail-safe2100000150%50% of 2
Appeal process2000100150%0% of 1
User and public consultation2100000150%50% of 2

Answered = records with any answer ÷ records in scope. In place of applicable = reported in place ÷ (in scope minus not applicable, precluded and waived). Unanswered records stay in that denominator, so the rate is a lower bound on reported evidence, not an estimate of real practice.

Agency-by-safeguard heatmap

Cell: share reported in place, among applicable recordsIn placeAnswered
Agency by governance practice
TestingImpact assess.Indep. reviewMonitoringTrainingFail-safeAppealConsultationn
VA––––––––1
STATE100%0%0%100%100%100%0%100%1

Hatched cells: the agency answered nothing for that practice, so there is no evidence either way. Compare agencies with care: each agency is one reporting unit, and portfolios differ in size and type.

Records requiring further investigation

2 records with at least one practice unanswered or in progressOpen in explorer
Use caseStageTestAIAReviewMonitorTrainFail-safeAppealConsult
Electronic Health Record AI Enhancements
STATE · R3248
DeployedReported in placeReported in progressReported in progressReported in placeReported in placeReported in placeNot applicableReported in place
Continuous Glucose Monitoring Summary
VA · VA-25-1506
DeployedNo answer reportedNo answer reportedNo answer reportedNo answer reportedNo answer reportedNo answer reportedNo answer reportedNo answer reported

Unanswered analytical questions

Generated from the data; for follow-up with agencies
  1. 1 high-impact use cases are reported as deployed while their AI impact assessment is reported in progress. Was deployment authorised before the assessment was complete?
  2. 1 high-impact use cases mark an appeal process as not applicable. On what basis was each individual outcome judged not contestable?

These are questions the inventory raises but cannot answer. They are not findings of non-compliance.